Avantor Strengthens Bioprocessing Leadership in AMEA Region with Appointment of Gladys Wang

Avantor, Inc., a global provider of mission-critical products and services to the life sciences and advanced technologies industries, has appointed Gladys Wang as Vice President, Bioprocessing Commercial for Asia, Middle East and Africa. Wang, based in Singapore, brings over twenty years of experience in life sciences and commercial leadership to the role, where she will oversee business expansion in the AMEA region, enhance customer success initiatives, and drive strategic partnerships throughout the bioprocessing ecosystem.

Wang's extensive background includes collaboration with biopharma manufacturers, contract development and manufacturing organizations, and key opinion leaders. She is recognized for delivering transformative business results through customer-centric strategies, operational excellence, and cross-market collaboration. Prior to joining Avantor, Wang held senior leadership positions at top life sciences organizations, including Head of Global Strategic Accounts APAC and Senior Director for Bioprocessing South Asia & Oceania, where she played a key role in accelerating Asia-Pacific expansion and achieving material business growth through disciplined market-entry strategies.

"The Asia, Middle East and Africa region is full of potential, and being part of a team that partners so closely with customers to advance innovation and strengthen manufacturing capabilities is truly motivating," said Wang. "The focus ahead will be on deepening collaboration, enhancing customer experience, and empowering teams to deliver meaningful impact across the bioprocessing value chain." Wang emphasized that contributing to Avantor's continued growth and supporting customers in reaching their scientific and operational objectives represents an exciting prospect for her leadership.

Wang holds a Master's degree in Biology from National Taiwan University and has completed executive programs at INSEAD and Stanford University, specializing in strategic transformation and innovation. With her commitment to excellence and talent for cultivating future leaders, Wang is expected to strengthen Avantor's position as a trusted partner for bioprocessing customers across the AMEA region. Avantor's portfolio is used in research, development and production activities at more than 300,000 customer locations in 180 countries, as detailed on their website at https://www.avantorsciences.com.

This appointment signals Avantor's strategic focus on the rapidly growing AMEA bioprocessing market, where increasing demand for biopharmaceuticals and advanced therapies requires sophisticated manufacturing capabilities and supply chain solutions. Wang's experience in market expansion and customer collaboration positions her to address regional challenges in bioprocessing scale-up, technology adoption, and regulatory compliance. The move reflects broader industry trends toward regional specialization and localized leadership to better serve diverse markets with varying regulatory environments and customer needs.

For the life sciences industry, effective regional leadership is crucial for navigating complex market dynamics, building local partnerships, and ensuring reliable supply of critical materials and technologies. Wang's appointment may influence how global bioprocessing companies approach the AMEA region, potentially encouraging greater investment in local infrastructure, talent development, and collaborative innovation. Customers in the region could benefit from more tailored solutions and enhanced support as Avantor strengthens its regional presence under Wang's leadership.